Cargando…
cGMP Signaling, Phosphodiesterases and Major Depressive Disorder
Deficits in neuroplasticity are hypothesized to underlie the pathophysiology of major depressive disorder (MDD): the effectiveness of antidepressants is thought to be related to the normalization of disrupted synaptic transmission and neurogenesis. The cyclic adenosine monophosphate (cAMP) signaling...
Autores principales: | Reierson, Gillian W, Guo, Shuyu, Mastronardi, Claudio, Licinio, Julio, Wong, Ma-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263465/ https://www.ncbi.nlm.nih.gov/pubmed/22654729 http://dx.doi.org/10.2174/157015911798376271 |
Ejemplares similares
-
Transient kinetics of a cGMP-dependent cGMP-specific phosphodiesterase from Dictyostelium discoideum
Publicado: (1984) -
In situ cGMP phosphodiesterase and photoreceptor potential in gecko retina
Publicado: (1986) -
Chronic fluoxetine treatment increases daytime melatonin synthesis in the rodent
por: Reierson, Gillian W, et al.
Publicado: (2009) -
Phosphodiesterase 9A in Brain Regulates cGMP Signaling Independent of Nitric-Oxide
por: Harms, John F., et al.
Publicado: (2019) -
The cGMP-phosphodiesterase and its contribution to sensitivity regulation in retinal rods
Publicado: (1995)